Evidence map›Paper›PMID 40744939›Full record

ArticleNPJ Parkinson's disease2025

Impact of α-synuclein fibril structure on seeding activity in experimental models of Parkinson's disease.

Junichiro Ohira, Masanori Sawamura, Kenichi Kawano, Risa Sato, Tomoyuki Taguchi, Tomoyuki Ishimoto, Jun Ueda, Masashi Ikuno, Shu-Ichi Matsuzawa, Katsumi Matsuzaki and 2 more

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Junichiro OhiraDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Masanori SawamuraDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kenichi KawanoGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Risa SatoGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Tomoyuki TaguchiDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Tomoyuki IshimotoDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Jun UedaDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Masashi IkunoDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Shu-Ichi MatsuzawaDepartment of Therapeutics for Multiple System Atrophy, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Katsumi MatsuzakiGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Ryosuke TakahashiKyoto University Office of Research Acceleration (KURA), Kyoto, Japan. ryosuket@kuhp.kyoto-u.ac.jp.
Hodaka YamakadoDepartment of Therapeutics for Multiple System Atrophy, Kyoto University Graduate School of Medicine, Kyoto, Japan. yamakado@kuhp.kyoto-u.ac.jp.

Funding

Japan Agency for Medical Research and Development 24wm0625503h0001Japan Agency for Medical Research and Development JP19dm0207070Japan Science and Technology Agency (JST) Moonshot Research and Development Program JPMJMS2024Japan Society for the Promotion of Science 21H04816Japan Society for the Promotion of Science 21J22787 and 22KJ1707
6 · The paper itself

Abstract

The central pathogenesis of Parkinson's disease involves the misfolding and aggregation of α-synuclein (α-syn). There is a widespread belief that α-syn can propagate in a prion-like manner, and α-syn preformed fibrils (PFFs) have been widely used to establish α-syn propagation models. However, achieving standardized protocols for generating PFFs is challenging due to the influence of various factors on propagation efficiency, resulting in inter-laboratory and inter-experimental variability. Among these factors, the size of the PFFs is considered the most influential as unsonicated PFFs exhibit limited seeding and propagation abilities. Therefore, the objective of our research is to examine the impact of the size and conformation of sonicated PFFs on seeding activity. PFFs were sonicated under various conditions using a conventional water bath sonicator and a high-power sonicator, which is commonly used for DNA shearing in next-generation sequencing. Each sonicated PFF was analyzed for in vitro/in vivo seeding activities, after size confirmation by electron microscopy and a conformational analysis by Fourier Transform Infrared (FTIR) spectroscopy. Strong sonication for 30 min generated extremely short fibrils with the highest seeding activity, which is the optimal condition for the propagation model, whereas sonication for 60 minutes or more led to a reduction in seeding activity. FTIR spectroscopy suggested that sonication disrupted the aggregated strands and generated new fibril ends, thereby accounting for the increased seeding activity; however, prolonged sonication for 60 min or more released monomers with disrupted β-sheet structure from PFFs and reduced the seeding activity. In conclusion, the balance between size reduction and preservation of the β-sheet structure in PFFs plays a critical role in seeding activity. Optimizing these parameters of α-syn PFFs can help improve reproducible preclinical animal models based on α-syn propagation.

Identifiers

PMID40744939
PMCPMC12313852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.